Compared with conventional T-cell-engineered CARs, the advantages of generating CD19-CAR γδ T cells include both CAR dependence toward CD19+ cells and natural γδT-cell cytotoxicity against CD19- leukemia cells [226]. This evidence concerns the gene CD19 and leukemia.